Table 2.
General algorithm for dose interruptions and reductions according to the severity of apatinib-associated adverse events.
| Grade of AE According to CTCAE | Treatment | Modification of Dose |
|---|---|---|
| Grade 1 or 2 | Unchanged | No modification |
| Grade 3 | Interruption until recovery to < grade 2 | First episode: try to restart at full dose Second episode: reduce the dose until the AE has reduced in severity by 1 grade |
| Grade 3 to 4 | As there is a risk of death, consider a permanent reduction or interruption | |
In some situations, grade 2 should lead to dose interruptions and reductions, e.g., wound complications and proteinuria. AE, adverse event; CTCAE, Common Terminology Criteria for Adverse Events.